| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |